We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Caprion Announces Biomarker Discovery Collaboration with Vertex
News

Caprion Announces Biomarker Discovery Collaboration with Vertex

Caprion Announces Biomarker Discovery Collaboration with Vertex
News

Caprion Announces Biomarker Discovery Collaboration with Vertex

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Caprion Announces Biomarker Discovery Collaboration with Vertex"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Caprion Pharmaceuticals Inc.'s Applied BioMedicine group has announced research collaboration with Vertex Pharmaceuticals Incorporated.

The collaboration will use Caprion's CellCarta® proteomics platform to support clinical biomarker discovery.

Caprion will identify potential pharmacodynamic biomarkers in samples from certain clinical and pre-clinical studies conducted by Vertex.

"Caprion is looking forward to working with Vertex on this clinical biomarker discovery collaboration," noted Dr. Daniel Chelsky, Chief Scientific Officer at Caprion.

"We believe that Caprion's capabilities in the discovery of protein biomarkers may significantly impact development efforts for one or more Vertex compounds."

Advertisement